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In this work we summarize our collaborative research on a project to develop absorption 
and fluorescence targeting probes. Several groups from University of Missouri and 
Harry S. Truman Memorial Veteran’s Hospital including Dr. Ma’s group, Dr. Yu’s group, 
Dr. Smith’s group, Dr. Hoffman’s group, and Professor Wynn Volkert have been 
involved in the project. Our goal is to develop probes based on mouse model for 
molecular optical imaging.  
In vivo imaging of targeted fluorescence molecular probes, or molecular imaging, is an 
emerging field in biomedical imaging. During the past forty years, three dimensional 
biomedical imaging technologies such as CT and MRI have been extensively used in 
human health and diseases. However, the human body is a complex and interactive 
biological system. A fundamental scientific barrier in previous biomedical imaging 
technologies is their limited ability to study physiological processes in vivo at the cellular 
and molecular levels. Molecular imaging technologies can overcome this barrier. Optical 
imaging modalities have the highest sensitivity compared to other imaging techniques. 
So they are good candidates for molecular imaging. We develop probes for two 
biomedical optical imaging techniques. The first technique is coherence domain 
imaging. This technique can be used to monitor interactions between targeted peptide 
conjugates and cancer cells at a tissue level. It requires absorption properties of the 
probe for effective molecular imaging. The second technique is fluorescence mediated 
tomographic imaging using an image-intensified CCD camera. This technique uses 
fluorescence of the probe for molecular imaging.  
Dye bombesin conjugates are synthesized for site-specific absorption and fluorescence 
imaging in human prostate and breast cancer cells. Bombesin (BBN), an amphibian 
analog to the endogenous ligand, binds to the gastrin releasing peptide receptors 
(GRPr) with high specificity and affinity. BBN conjugates have a specific significance in 
cancer detection and therapy due to high over-expression levels of GRPrs in human 
cancer cells. Previously, we have developed an Alexa Fluor 680 BBN peptide 
conjugate. This probe can not be used as an absorption probe in near-infrared imaging 
since its absorption peak is in the visible wavelength range. In addition, long wavelength 
fluorescence is desired because long wavelength photons can penetrate deeper into 
tissue when using the conjugates as a fluorescent probe. The new absorption and 
fluorescent probe we developed is based on the last eight-residues of BBN and labeled 
with Alexa Fluor 750 through an effective linker. The developed probe, AF750-BetaAla-
BBN[7-14]NH2,  exhibits optimal pharmacokinetic properties for targeting GRPr over-
expressing cancer cells in mice. Absorption spectra have been measured and showed 
absorption peaks at 690nm, 720nm and 735nm. Fluorescent band is located at 755nm. 
Fluorescent microscopic imaging of the conjugates
 
in human PC-3 prostate cancer and 
T-47D breast cancer cells indicated specific uptake and internalization in vitro. In vivo 
optical and MR imaging was performed in SCID mice bearing human breast and 
prostate xenografts. In vitro and in vivo studies have demonstrated the effectiveness of 
the fluorescent probe Alexa Fluor 750-BetaAla-BBN[7-14]NH2 to specifically target 
GRPr overexpressed cancer tissues. 
 
